The novel aminoglycoside, ELX-02, permits CTNSW138X translational read-through and restores lysosomal cystine efflux in cystinosis.
BACKGROUND:Cystinosis is a rare disorder caused by recessive mutations of the CTNS gene. Current therapy decreases cystine accumulation, thus slowing organ deterioration without reversing renal Fanconi syndrome or preventing eventual need for a kidney transplant.15-20% of cystinosis patients harbour...
Main Authors: | Emma J Brasell, Lee Lee Chu, Murielle M Akpa, Idit Eshkar-Oren, Iris Alroy, Rachel Corsini, Brian M Gilfix, Yojiro Yamanaka, Pedro Huertas, Paul Goodyer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0223954 |
Similar Items
-
Non-invasive intradermal imaging of cystine crystals in cystinosis.
by: Marya Bengali, et al.
Published: (2021-01-01) -
Treatment of corneal cystine crystal accumulation in patients with cystinosis
by: Shams F, et al.
Published: (2014-10-01) -
The History of Cystinosis: Lessons for Clinical Management
by: Paul Goodyer
Published: (2011-01-01) -
Implementation of a method to quantify white blood cell cystine as a diagnostic support for cystinosis
by: Johana Maria Guevara-Morales, et al.
Published: (2020-01-01) -
Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review
by: Makuloluwa AK, et al.
Published: (2018-01-01)